Cellyan Biotechnology Co., Ltd (HKPD)
Cellyan Biotechnology Co., Ltd operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Yau Tong, HK. The stock last traded at $0.42, up 1.12% on the session, giving a market capitalisation of $4.6M. On trailing twelve-month figures it carries a trailing P/E of -6.09, a net margin of -4.3%. Its beta of 2.33 implies it has historically moved more than the broad market.
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Cellyan Biotechnology Co., Ltd is most often compared with the following Healthcare names: